Last reviewed · How we verify
NCT04479059
Endometrial Follicular Fluid Flushing and IVF Outcome
NA trial testing follicular fluid flushing in Clinical Pregnancy in 100 participants. Completed in 31 May 2017.
30 May 2017
Quick facts
| Lead sponsor | Zeynep Kamil Maternity and Pediatric Research and Training Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 October 2016 |
| Primary completion | 30 May 2017 |
| Estimated completion | 31 May 2017 |
Drugs / interventions tested
- follicular fluid flushing
Conditions studied
- Clinical Pregnancy — all drugs for Clinical Pregnancy →
Sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Who can join
Adults 20 to 39, female only, with Clinical Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: In this study, our aim will be investigating the pregnancy results in unexplained infertile women undergoing ICSI, by flushing the endometrial cavity with folliculer fluid, that we maintain mature follicules inside them in oocyte retrieval day. Study Design: 100 subfertile women who applied to Zeynep Kamil Hospital, In Vitro Fertilization Center between October 2016 to May 2017 will be randomized with computer generated programme. The patients will be divided into two groups; follicular fluid group (n=50) and control group (n=50). The inclusion criterias are: age between 20-39 years, basal FSH level \< 10 mIU/ml, body mass index\<35 kg/m2 and E2 levels in human chorionic gonadotropin (hCG) day between 1000-4000 pg/ml. Patients meets these criteria will be included to the study programme. The exclusion criteria are determined as below: previously diagnosed endometriosis, uterine leiomyomas, hydrosalpinx, endocrinological disorders; previous history of implantation failure in IVF/ICSI cycles and severe male factor infertility.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04479059
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Zeynep Kamil Maternity and Pediatric Research and Training Hospital trials
Trials by the same sponsor.
- NCT05786352 — Outcomes of Enhanced Recovery After Cesarean (ERAC) Protocol · NA · unknown
- NCT07312617 — Short-Term Outcomes of TOT, TVT, and Burch Surgery Assessed by Transperineal Ultrasound · NA · completed
- NCT05558046 — Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique · unknown
- NCT05558852 — Laparoscopic Central and Anterior Compartment Prolapse Surgery: A Meshless Sacrocolpopexy Technique · NA · unknown
- NCT04888091 — Comparison of the Effect of Cervical Mucus Cleaning Method Applied Before Embryo Transfer on Pregnancy Rates. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04479059 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zeynep Kamil Maternity and Pediatric Research and Training Hospital
- Last refreshed: 21 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04479059.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing